MedTrace Logo

Effects of Omega-3 and Whey Protein Supplementation on Lean Mass in Older Adults

NCT05862779 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-10-16

No results posted yet for this study

Summary

To evaluate the effect of omega-3 supplementation combined with whey protein intake on lean mass and strength gains in older adults performing resistance exercise. Participants will be randomized into the 4 groups. The placebo group will receive 4 g per day of corn oil and 40 g per day of maltodextrin. The omega 3 + placebo group will receive 4 g per day of fish oil and 40 g per day of maltodextrin. The whey protein + placebo group will receive 40g per day of whey and 4g per day of corn oil. The omega 3 + whey group will receive 4g per day of fish oil and 40g per day of protein. All will perform the same exercise protocol for 12 weeks

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo Group

The placebo group will receive 4 g per day of corn oil and 40 g per day of maltodextrin.

DIETARY_SUPPLEMENT

Whey Protein + Placebo

The whey protein + placebo group will receive 40g per day of whey and 4g per day of corn oil.

DIETARY_SUPPLEMENT

Omega 3 + Placebo

The omega 3 + placebo group will receive 4 g per day of fish oil and 40 g per day of maltodextrin.

DIETARY_SUPPLEMENT

Omega 3 + Whey Protein

The omega 3 + whey group will receive 4g per day of fish oil and 40g per day of protein.

Sponsors & Collaborators

  • Federal University of Uberlandia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2025-12-31
Completion
2026-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862779 on ClinicalTrials.gov